FindMyKOL
Clinical trialNCT06802224RecruitingPhase 4Interventional

The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery

SponsorUniversity of California, San FranciscoEnrollment18,000Acute Kidney Injury (AKI)AnesthesiaHypotension During SurgeryMyocardial Injury After Noncardiac Surgery (MINS)Noncardiac SurgerySurgery With General Anesthesia+1 more conditions
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Low blood pressure, also known as hypotension, is very common during major surgery under general anesthesia. Prolonged or severe hypotension can lead to complications such as kidney injury after surgery that slow down patient recovery. Anesthesiologists commonly administer medications called vasopressors to treat low blood pressure during surgery. These medications help raise the blood pressure back up to a safe range. Two vasopressor medications are commonly used for this purpose: norepinephrine and phenylephrine. Each of these medications has slightly different effects on the heart and blood vessels (cardiovascular system). It remains unknown which of these standard medications is better for treating low blood pressure during surgery. The goal of this clinical trial is to determine which of these two medications is better at preventing injury to the kidneys after major noncardiac surgery as well as other complications such as heart problems. Major surgeries are defined as those lasting at least two hours under general anesthesia. This trial will randomize about ten centers in North America to use either norepinephrine or phenylephrine as the primary medication to treat low blood pressure in adults undergoing major noncardiac surgery. Each hospital will prioritize one of the drugs each month, and the assigned drug will rotate each month at each hospital. No further participant involvement will be required as de-identified data are collected as part of standard medical care.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • University Health Network

    Toronto, Ontario, Canada

    Tariq Esmail, MD
    Recruiting
United States
  • University of California, San Francisco

    San Francisco, California, United States

    Matthieu Legrand, MD PhDMichael P Bokoch, MD PhD
    Recruiting
  • University of Maryland

    College Park, Maryland, United States

    Megan Anders, MD
    Recruiting
  • University of Michigan

    Ann Arbor, Michigan, United States

    Allison Janda, MDSachin Kheterpal, MD, MBA
    Recruiting
  • Henry Ford Health

    Detroit, Michigan, United States

    Mousab M Eteer, MD
    Recruiting
  • Duke University Medical Center

    Durham, North Carolina, United States

    Michael Manning, MD
    Recruiting
  • Wake Forest University School of Medicine

    Winston-Salem, North Carolina, United States

    Ashish Khanna, MD
    Recruiting
  • Ut Southwestern Medical Center

    Dallas, Texas, United States

    Siddharth Dave, MD
    Recruiting
  • University of Virginia

    Charlottesville, Virginia, United States

    Bhiken Naik, MD
    Recruiting
  • University of Washington

    Seattle, Washington, United States

    John Lang, MDKaren B Domino, MDWil Van Cleve, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

NorepinephrinePhenylephrine →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Apr 2025
Primary completion
31 Jul 2028
Completion
31 Jul 2028
Last update posted
26 May 2026
Registered enrollment
18,000
Registry id
NCT06802224

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.